Improving Mycobacterium bovis bacillus Calmette-Guèrin as a vaccine delivery vector for viral antigens by incorporation of glycolipid activators of NKT cells.
Recombinant Mycobacterium bovis bacillus Calmette-Guèrin (rBCG) has been explored as a vector for vaccines against HIV because of its ability to induce long lasting humoral and cell mediated immune responses. To maximize the potential for rBCG vaccines to induce effective immunity against HIV, vario...
保存先:
| 主要な著者: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Public Library of Science (PLoS)
2014-01-01
|
| シリーズ: | PLoS ONE |
| オンライン・アクセス: | https://doi.org/10.1371/journal.pone.0108383 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
